These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 22975610)
21. [Antivasoproliferative agents in ophthalmology]. Ambresin A; Zografos L; Mantel I Rev Med Suisse; 2010 Jan; 6(231):51-4. PubMed ID: 20196434 [TBL] [Abstract][Full Text] [Related]
22. Introduction, mechanism of action and rationale for anti-vascular endothelial growth factor drugs in age-related macular degeneration. Kim R Indian J Ophthalmol; 2007; 55(6):413-5. PubMed ID: 17951895 [TBL] [Abstract][Full Text] [Related]
23. The future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice. Hussain N; Ghanekar Y; Kaur I Indian J Ophthalmol; 2007; 55(6):445-50. PubMed ID: 17951902 [TBL] [Abstract][Full Text] [Related]
28. Evolving Knowledge in Pharmacologic Treatments of Age-Related Macular Degeneration. Soubrane Daguet G; Risard-Gasiorowski S; Massamba N Dev Ophthalmol; 2016; 55():1-6. PubMed ID: 26501927 [TBL] [Abstract][Full Text] [Related]
29. Use of radiation in the treatment of age-related macular degeneration. Flaxel CJ Ophthalmol Clin North Am; 2002 Dec; 15(4):437-44, v. PubMed ID: 12515075 [TBL] [Abstract][Full Text] [Related]
30. Drop in well-being of ARMD patients under treatment with anti-VEGF injections during the COVID-19 pandemic. Mylona I; Papadopoulou K; Roumelis S; Floros GD Int Ophthalmol; 2022 Aug; 42(8):2493-2499. PubMed ID: 35362811 [TBL] [Abstract][Full Text] [Related]
31. Kilovoltage radiosurgery with gold nanoparticles for neovascular age-related macular degeneration (AMD): a Monte Carlo evaluation. Brivio D; Zygmanski P; Arnoldussen M; Hanlon J; Chell E; Sajo E; Makrigiorgos GM; Ngwa W Phys Med Biol; 2015 Dec; 60(24):9203-13. PubMed ID: 26576672 [TBL] [Abstract][Full Text] [Related]
32. What is the role of radiation in the treatment of subfoveal membranes: review of radiobiologic, pathologic, and other considerations to initiate a multimodality discussion. Archambeau JO; Mao XW; Yonemoto LT; Slater JD; Friedrichsen E; Teichman S; Preston W; Slater JM Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1125-36. PubMed ID: 9539568 [TBL] [Abstract][Full Text] [Related]
33. Stereotactic radiotherapy for wet age-related macular degeneration: current perspectives. Neffendorf JE; Jackson TL Clin Ophthalmol; 2015; 9():1829-34. PubMed ID: 26491243 [TBL] [Abstract][Full Text] [Related]
34. [Brachytherapy in the treatment of age-related macular degeneration]. Furdová A; Strmen P Bratisl Lek Listy; 2000; 101(4):234-6. PubMed ID: 10914474 [TBL] [Abstract][Full Text] [Related]
35. [Radiotherapy and age-related macular degeneration: a review of the literature]. Schwartz LH; Schmitt T; Benchaboun M; Caputo G; Chauvaud D; Balosso J; Faivre C; Français C; Koenig F Cancer Radiother; 1997; 1(3):208-12. PubMed ID: 9295874 [TBL] [Abstract][Full Text] [Related]
36. [Radiation-induced retinopathy: actual knowledge and new concepts]. Gilli C; Thariat J; Chacun S; Nguyen AM; Loria O; Kodjikian L; Mathis T Cancer Radiother; 2022 Nov; 26(8):1090-1099. PubMed ID: 35879145 [TBL] [Abstract][Full Text] [Related]